Yumanity Therapeutics announces first clinical candidate for the potential treatment of Parkinson’s disease

First-in-Human Trials Planned for the Fourth Quarter of 2019 IND-Enabling Studies to Be Completed Utilizing Evotec INDiGO Platform

Topics: Corporate, Evotec, Yumanity Therapeutics, Parkinson's disease, INDiGO, IND Enabling Read More

Evotec to Acquire Aptuit, Expanding Leadership in External Innovation

We are pleased to share the press release published today about the agreement between Evotec AG and Aptuit under which Evotec will acquire Aptuit.

Topics: Acquisition, Corporate, Contract Reseach Organization, Drug Discovery, Drug Development, Integrated CMC, IND Enabling, Partner Research Organization Read More

Most Read

Posts by Topic